236 related articles for article (PubMed ID: 19514444)
1. [Analysis of the clinical features and outcome of ventilator-associated Pseudomonas aeruginosa-related pneumonia in an intensive care unit].
Baĭgozina EA; Sovalkin VI; Lukach VN
Anesteziol Reanimatol; 2009; (2):62-4. PubMed ID: 19514444
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of clinical features and outcome of nosocomial pneumonia caused by Pseudomonas aeruginosa].
Baĭgozina EA
Klin Med (Mosk); 2009; 87(6):57-9. PubMed ID: 19670720
[TBL] [Abstract][Full Text] [Related]
3. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
4. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
5. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
[TBL] [Abstract][Full Text] [Related]
6. Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
Deconinck L; Meybeck A; Patoz P; Van Grunderbeeck N; Boussekey N; Chiche A; Delannoy PY; Georges H; Leroy O
Infect Dis (Lond); 2017 May; 49(5):396-404. PubMed ID: 28092204
[TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.
Yamada K; Yanagihara K; Kaku N; Harada Y; Migiyama Y; Nagaoka K; Morinaga Y; Nakamura S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Hasegawa H; Yasuoka A; Kohno S
Int J Antimicrob Agents; 2013 Sep; 42(3):238-43. PubMed ID: 23891525
[TBL] [Abstract][Full Text] [Related]
8. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndrome.
Migiyama Y; Hirosako S; Tokunaga K; Migiyama E; Tashiro T; Sagishima K; Kamohara H; Kinoshita Y; Kohrogi H
Pulm Pharmacol Ther; 2017 Aug; 45():142-147. PubMed ID: 28450200
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification.
Micek ST; Kollef MH; Torres A; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Wunderink R; Menichetti F; Schramm G; Menon V
Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1190-7. PubMed ID: 26190444
[TBL] [Abstract][Full Text] [Related]
11. Superinfections in Pseudomonas aeruginosa ventilator-associated pneumonia.
Giantsou E; Manolas KI
Minerva Anestesiol; 2011 Oct; 77(10):964-70. PubMed ID: 21952596
[TBL] [Abstract][Full Text] [Related]
12. Nebulized imipenem to control nosocomial pneumonia caused by Pseudomonas aeruginosa.
Radhakrishnan M; Jaganath A; Rao GS; Kumari HB
J Crit Care; 2008 Mar; 23(1):148-50. PubMed ID: 18359432
[No Abstract] [Full Text] [Related]
13. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Intensive Care Med; 2006 Dec; 32(12):1970-8. PubMed ID: 16957901
[TBL] [Abstract][Full Text] [Related]
14. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
15. Lower respiratory tract microbial composition was diversified in Pseudomonas aeruginosa ventilator-associated pneumonia patients.
Qi X; Qu H; Yang D; Zhou L; He YW; Yu Y; Qu J; Liu J
Respir Res; 2018 Jul; 19(1):139. PubMed ID: 30049266
[TBL] [Abstract][Full Text] [Related]
16. Ventilator-associated pneumonia: role of colonizers and value of routine endotracheal aspirate cultures.
Joseph NM; Sistla S; Dutta TK; Badhe AS; Parija SC
Int J Infect Dis; 2010 Aug; 14(8):e723-9. PubMed ID: 20542716
[TBL] [Abstract][Full Text] [Related]
17. Ventilator-associated pneumonia due to Pseudomonas aeruginosa.
Crouch Brewer S; Wunderink RG; Jones CB; Leeper KV
Chest; 1996 Apr; 109(4):1019-29. PubMed ID: 8635325
[TBL] [Abstract][Full Text] [Related]
18. Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.
Kaminski C; Timsit JF; Dubois Y; Zahar JR; Garrouste-Orgeas M; Vesin A; Azoulay E; Feger C; Dumenil AS; Adrie C; Cohen Y; Allaouchiche B;
Crit Care; 2011; 15(2):R112. PubMed ID: 21481266
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning Methods Applied to Predict Ventilator-Associated Pneumonia with
Liao YH; Wang ZC; Zhang FG; Abbod MF; Shih CH; Shieh JS
Sensors (Basel); 2019 Apr; 19(8):. PubMed ID: 31003541
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation.
Bassetti M; Villa G; Pecori D
Future Microbiol; 2014; 9(4):465-74. PubMed ID: 24810346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
